Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Covid-19"" wg kryterium: Temat


Tytuł :
Interpreting SARS-CoV-2 Diagnostic Tests: Common Questions and Answers.
Autorzy :
Nettleton WD; Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA.
Pokaż więcej
Źródło :
American family physician [Am Fam Physician] 2021 Apr 15; Vol. 103 (8), pp. 465-472.
Typ publikacji :
Journal Article
MeSH Terms :
Asymptomatic Infections*
COVID-19*/diagnosis
COVID-19*/immunology
COVID-19*/physiopathology
COVID-19*/prevention & control
Carrier State*/transmission
Carrier State*/virology
COVID-19 Testing/*methods
COVID-19 Nucleic Acid Testing/methods ; COVID-19 Serological Testing/methods ; Contact Tracing/methods ; Diagnostic Errors ; Disease Transmission, Infectious/prevention & control ; Humans ; Predictive Value of Tests
Czasopismo naukowe
Tytuł :
Brief review on repurposed drugs and vaccines for possible treatment of COVID-19.
Autorzy :
De P; Department of Biophysics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.
Chakraborty I; Department of Biophysics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.
Karna B; Department of Molecular Medicine, Ulm University, Ulm, Germany.
Mazumder N; Department of Biophysics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India. Electronic address: .
Pokaż więcej
Źródło :
European journal of pharmacology [Eur J Pharmacol] 2021 May 05; Vol. 898, pp. 173977. Date of Electronic Publication: 2021 Feb 25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19 Vaccines*
SARS-CoV-2*/immunology
Antiviral Agents/*administration & dosage
COVID-19/*drug therapy
Antiviral Agents/adverse effects ; COVID-19/diagnosis ; COVID-19/prevention & control ; COVID-19 Testing ; Drug Repositioning ; Humans ; Plants, Medicinal
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
[Effectiveness of the first dose of BNT162b2 vaccine to preventing covid-19 in healthcare personnel.]
Autorzy :
Gras-Valentí P; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Chico-Sánchez P; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Algado-Sellés N; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Jiménez-Sepúlveda NJ; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Gómez-Sotero IL; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Fuster-Pérez M; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.; Comisión de Infección Hospitalaria, Profilaxis y Política Antibiótica. Hospital General Universitario de Alicante. Alicante. España.
Cartagena-Llopis L; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Sánchez-Valero M; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Cerezo-Milán P; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Martínez-Tornero I; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Tremiño-Sánchez L; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Nadal-Morante V; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Monerris-Palmer M; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Esclapez-Martínez A; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
MorenodeArcos-Fuentes E; Servicio de Pediatría. Hospital General Universitario de Alicante. Alicante. España.
Escalada-Martín I; Servicio de Pediatría. Hospital General Universitario de Alicante. Alicante. España.
Escribano-Cañadas I; Servicio de Microbiología. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Merino-Lucas E; Comisión de Infección Hospitalaria, Profilaxis y Política Antibiótica. Hospital General Universitario de Alicante. Alicante. España.; Unidad de Enfermedades Infecciosas. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.
Rodríguez-Díaz JC; Servicio de Microbiología. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.; Comisión de Infección Hospitalaria, Profilaxis y Política Antibiótica. Hospital General Universitario de Alicante. Alicante. España.
Sánchez-Payá J; Unidad de Epidemiología. Servicio de Medicina Preventiva. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). Alicante. España.; Comisión de Infección Hospitalaria, Profilaxis y Política Antibiótica. Hospital General Universitario de Alicante. Alicante. España.
Pokaż więcej
Transliterated Title :
Efectividad de la primera dosis de vacuna BNT162b2 para prevenir la COVID-19 en personal sanitario.
Źródło :
Revista espanola de salud publica [Rev Esp Salud Publica] 2021 Apr 29; Vol. 95. Date of Electronic Publication: 2021 Apr 29.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Vaccines*
Health Personnel*
COVID-19/*prevention & control
Adult ; COVID-19/diagnosis ; COVID-19 Nucleic Acid Testing ; Case-Control Studies ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Spain ; Treatment Outcome
Czasopismo naukowe
Tytuł :
SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.
Autorzy :
Keehner J; UC San Diego Health, San Diego, CA.
Horton LE; UC San Diego Health, San Diego, CA.
Pfeffer MA; David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA.
Longhurst CA; UC San Diego Health, San Diego, CA.
Schooley RT; UC San Diego Health, San Diego, CA.
Currier JS; David Geffen School of Medicine at UCLA, Los Angeles, CA.
Abeles SR; UC San Diego Health, San Diego, CA .
Torriani FJ; UC San Diego Health, San Diego, CA .
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 May 06; Vol. 384 (18), pp. 1774-1775. Date of Electronic Publication: 2021 Mar 23.
Typ publikacji :
Letter
MeSH Terms :
Asymptomatic Diseases*
COVID-19 Vaccines*
Health Personnel*
COVID-19/*epidemiology
SARS-CoV-2/*isolation & purification
COVID-19/diagnosis ; COVID-19 Testing ; California/epidemiology ; Humans ; Vaccination ; Vaccines, Synthetic
Opinia redakcyjna
Tytuł :
Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: A cross-sectional study.
Autorzy :
Szépfalusi Z; Division of Pediatric Pulmonology, Allergy and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Centre of Pediatrics, Medical University of Vienna, Vienna, Austria.
Schmidthaler K; Division of Pediatric Pulmonology, Allergy and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Centre of Pediatrics, Medical University of Vienna, Vienna, Austria.
Sieber J; Division of Pediatric Pulmonology, Allergy and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Centre of Pediatrics, Medical University of Vienna, Vienna, Austria.; Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.
Kopanja S; Division of Pediatric Pulmonology, Allergy and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Centre of Pediatrics, Medical University of Vienna, Vienna, Austria.
Götzinger F; Department of Pediatrics and Adolescent Medicine, Klinik Ottakring, Vienna, Austria.
Schoof A; Division of Pediatric Pulmonology, Allergy and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Centre of Pediatrics, Medical University of Vienna, Vienna, Austria.
Hoz J; Division of Pediatric Pulmonology, Allergy and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Centre of Pediatrics, Medical University of Vienna, Vienna, Austria.
Willinger B; Division of Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Makristathis A; Division of Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Weseslindtner L; Centre for Virology, Medical University of Vienna, Vienna, Austria.
Stiasny K; Centre for Virology, Medical University of Vienna, Vienna, Austria.
Bohle B; Institute of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Krotka P; Institute for Medical Statistics, Centre for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
Graf A; Institute for Medical Statistics, Centre for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
Frischer T; Department of Pediatrics and Adolescent Medicine, Klinik Ottakring, Vienna, Austria.; Sigmund Freud Private University, Vienna, Austria.
Pokaż więcej
Źródło :
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2021 May; Vol. 32 (4), pp. 762-770. Date of Electronic Publication: 2021 Feb 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19 Serological Testing*
COVID-19/*diagnosis
SARS-CoV-2/*immunology
Adolescent ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; COVID-19/transmission ; COVID-19 Nucleic Acid Testing ; Child ; Child, Preschool ; Cross-Sectional Studies ; Female ; Humans ; Male ; Seroepidemiologic Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key.
Autorzy :
Ferguson J; Institute of Cancer and Genomic Science, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
Dunn S; Institute of Microbiology and Infection, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
Best A; Clinical Immunology Service, Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
Mirza J; Clinical Immunology Service, Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
Percival B; Clinical Immunology Service, Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
Mayhew M; Clinical Immunology Service, Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
Megram O; Clinical Immunology Service, Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
Ashford F; Clinical Immunology Service, Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
White T; Clinical Immunology Service, Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
Moles-Garcia E; Clinical Immunology Service, Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
Crawford L; Clinical Immunology Service, Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
Plant T; Clinical Immunology Service, Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
Bosworth A; University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Kidd M; Public Health England, Birmingham, United Kingdom.
Richter A; Institute of Cancer and Genomic Science, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
Deeks J; Institute of Applied Health Research, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.; NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, United Kingdom.
McNally A; Institute of Microbiology and Infection, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.
Pokaż więcej
Źródło :
PLoS biology [PLoS Biol] 2021 Apr 29; Vol. 19 (4), pp. e3001216. Date of Electronic Publication: 2021 Apr 29 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
COVID-19 Serological Testing*
COVID-19/*diagnosis
Carrier State/*diagnosis
SARS-CoV-2/*isolation & purification
COVID-19/epidemiology ; COVID-19 Nucleic Acid Testing ; Carrier State/epidemiology ; Humans ; Immunoassay ; Mass Screening ; Prevalence ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology ; Sensitivity and Specificity ; United Kingdom/epidemiology ; Universities
Czasopismo naukowe
Tytuł :
Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients.
Autorzy :
Thommes L; Department of Internal Medicine II, Infectious Disease, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Innsbruck, Austria.
Burkert FR; Department of Internal Medicine II, Infectious Disease, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Innsbruck, Austria.
Öttl KW; Department of Internal Medicine II, Infectious Disease, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Innsbruck, Austria.
Goldin D; Department of Internal Medicine II, Infectious Disease, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Innsbruck, Austria.
Loacker L; Central Institute for Medical and Chemical Laboratory Diagnosis, Innsbruck University Hospital, Innsbruck, Austria.
Lanser L; Department of Internal Medicine II, Infectious Disease, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Innsbruck, Austria.
Griesmacher A; Central Institute for Medical and Chemical Laboratory Diagnosis, Innsbruck University Hospital, Innsbruck, Austria.
Theurl I; Department of Internal Medicine II, Infectious Disease, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Innsbruck, Austria.
Weiss G; Department of Internal Medicine II, Infectious Disease, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: .
Bellmann-Weiler R; Department of Internal Medicine II, Infectious Disease, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: .
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Apr; Vol. 105, pp. 144-146. Date of Electronic Publication: 2021 Feb 17.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
COVID-19 Serological Testing*
Antigens, Viral/*analysis
COVID-19/*diagnosis
SARS-CoV-2/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; COVID-19 Nucleic Acid Testing ; Female ; Hospitalization ; Humans ; Male ; Middle Aged ; Nasopharynx/virology ; Young Adult
Czasopismo naukowe
Tytuł :
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
Autorzy :
Stefanelli P; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy. Electronic address: .
Bella A; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Fedele G; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Pancheri S; APSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy.
Leone P; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Vacca P; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Neri A; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Carannante A; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Fazio C; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Benedetti E; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Fiore S; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Fabiani C; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Simmaco M; Hospital Direction and Clinical Departments, Sant'Andrea University Hospital, Rome, Italy.
Santino I; Hospital Direction and Clinical Departments, Sant'Andrea University Hospital, Rome, Italy.
Zuccali MG; APSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy.
Bizzarri G; APSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy.
Magnoni R; APSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy.
Benetollo PP; APSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy.
Merler S; Center for Information Technology, Bruno Kessler Foundation, Trento, Italy.
Brusaferro S; Istituto Superiore di Sanità, Rome, Italy.
Rezza G; Health Prevention Directorate, Ministry of Health, Rome, Italy.
Ferro A; APSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy.
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Apr; Vol. 27 (4), pp. 633.e1-633.e7. Date of Electronic Publication: 2020 Nov 28.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Serological Testing*
Antibodies, Viral/*blood
COVID-19/*epidemiology
Immunoglobulin G/*blood
SARS-CoV-2/*immunology
Adolescent ; Adult ; Aged ; COVID-19/immunology ; COVID-19 Nucleic Acid Testing ; Female ; Humans ; Incidence ; Italy/epidemiology ; Male ; Middle Aged ; Seroepidemiologic Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.
Autorzy :
Mina MJ; Center for Communicable Disease Dynamics, Department of Epidemiology and Department of Immunology and Infectious Diseases, Harvard T H Chan School of Public Health and Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Peto TE; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
García-Fiñana M; Institute of Population Health, University of Liverpool, Liverpool L36 3GF, UK.
Semple MG; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
Buchan IE; Institute of Population Health, University of Liverpool, Liverpool L36 3GF, UK. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Apr 17; Vol. 397 (10283), pp. 1425-1427. Date of Electronic Publication: 2021 Feb 17.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Serological Testing*
Public Health Administration*
COVID-19/*diagnosis
COVID-19 Nucleic Acid Testing ; Humans ; SARS-CoV-2 ; Sensitivity and Specificity ; United Kingdom
Czasopismo naukowe
Tytuł :
COVID-19 re-infection: Diagnostic challenges and proposed diagnostic criteria.
Autorzy :
Raveendran AV; Govt. Medical College,Manjeri,Kottayam, Kozhikode, Kerala, India. Electronic address: .
Pokaż więcej
Źródło :
Diabetes & metabolic syndrome [Diabetes Metab Syndr] 2021 Mar-Apr; Vol. 15 (2), pp. 645-648. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :
Letter
MeSH Terms :
COVID-19 Testing*/classification
COVID-19 Testing*/methods
COVID-19 Testing*/standards
COVID-19/*diagnosis
Reinfection/*diagnosis
Acute Disease ; Asymptomatic Infections/epidemiology ; COVID-19/epidemiology ; COVID-19 Nucleic Acid Testing ; Carrier State/diagnosis ; Carrier State/epidemiology ; Carrier State/virology ; Humans ; Polymorphism, Single Nucleotide ; Practice Guidelines as Topic ; Reinfection/epidemiology ; Reproducibility of Results ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification
Opinia redakcyjna
Tytuł :
Seroprevalence Study and Cross-Sectional Survey on COVID-19 for a Plan to Reopen the University of Alicante (Spain).
Autorzy :
Tuells J; Department of Community Nursing, Preventive Medicine, Public Health and History of Science, University of Alicante, 03690 Alicante, Spain.
Egoavil CM; Clinical Pharmacology Unit, General University Hospital of Alicante, Institute for Health and Biomedical Research (ISABIAL Foundation), C/Pintor Baeza, 12, 03010 Alicante, Spain.
Pena Pardo MA; Clinical Pharmacology Unit, General University Hospital of Alicante, Institute for Health and Biomedical Research (ISABIAL Foundation), C/Pintor Baeza, 12, 03010 Alicante, Spain.
Montagud AC; Immunology Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Montagud E; Primary Care Pharmacy Service, University Hospital of Torrevieja, 03186 Torrevieja, Alicante, Spain.
Caballero P; Department of Community Nursing, Preventive Medicine, Public Health and History of Science, University of Alicante, 03690 Alicante, Spain.
Zapater P; Clinical Pharmacology Unit, General University Hospital of Alicante, Institute for Health and Biomedical Research (ISABIAL Foundation), C/Pintor Baeza, 12, 03010 Alicante, Spain.
Puig-Barberá J; Vaccines Research Area FISABIO, 46020 Valencia, Spain.
Hurtado-Sanchez JA; Faculty of Health Sciences, University of Alicante, 03690 Alicante, Spain.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Feb 16; Vol. 18 (4). Date of Electronic Publication: 2021 Feb 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19 Serological Testing*
Seroepidemiologic Studies*
Universities*
COVID-19/*diagnosis
Adult ; COVID-19/prevention & control ; COVID-19 Vaccines ; Cross-Sectional Studies ; Faculty ; Female ; Health Knowledge, Attitudes, Practice ; Humans ; Immunoassay ; Male ; Middle Aged ; Personal Protective Equipment ; Spain/epidemiology ; Students ; Young Adult
Czasopismo naukowe
Tytuł :
Covid-19 will not "magically disappear": Why access to widespread testing is paramount.
Autorzy :
George PE; Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta.; Emory University School of Medicine.
Stokes CL; Emory University School of Medicine.
Bassit LC; Emory University School of Medicine.; Department of Pediatrics, Laboratory of Biochemical Pharmacology.; Children's Healthcare of Atlanta.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
Chahroudi A; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
Figueroa J; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
Griffiths MA; Emory University School of Medicine.; Children's Healthcare of Atlanta.
Heilman S; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
Ku DN; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.; Georgia Institute of Technology, GWW School of Mechanical Engineering.
Nehl EJ; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.; Emory University Rollins School of Public Health.; Georgia Clinical & Translational Science Alliance, Atlanta, GA.
Leong T; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.; Emory University Rollins School of Public Health.
Levy JM; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
Kempker R; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
Mannino RG; Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta.; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology.
Mavigner M; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta.
Park SI; Children's Healthcare of Atlanta.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.; Emory School of Medicine.
Rao A; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
Rebolledo PA; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.; Emory University Rollins School of Public Health.
Roback JD; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.; Center for Transfusion and Cellular Therapies.
Rogers BB; Emory University School of Medicine.; Children's Healthcare of Atlanta.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
Schinazi RF; Emory University School of Medicine.; Department of Pediatrics, Laboratory of Biochemical Pharmacology.; Children's Healthcare of Atlanta.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
Sullivan J; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
Tyburski EA; Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta.; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology.
Vos MB; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.; Center for Transfusion and Cellular Therapies.
Waggoner JJ; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
Wang YF; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
Madsen J; MITRE.
Wechsler DS; Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta.; Emory University School of Medicine.
Joiner CH; Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta.; Emory University School of Medicine.
Martin GS; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
Lam WA; Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta.; Emory University School of Medicine.; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology.
Pokaż więcej
Źródło :
American journal of hematology [Am J Hematol] 2021 Feb 01; Vol. 96 (2), pp. 174-178. Date of Electronic Publication: 2020 Dec 30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
COVID-19 Testing*/economics
COVID-19 Testing*/methods
COVID-19 Testing*/statistics & numerical data
Health Services Accessibility*
Pandemics*
COVID-19/*diagnosis
SARS-CoV-2/*isolation & purification
Antigens, Viral/analysis ; Antigens, Viral/immunology ; COVID-19/epidemiology ; COVID-19 Nucleic Acid Testing ; Coronavirus Nucleocapsid Proteins/analysis ; Coronavirus Nucleocapsid Proteins/immunology ; Cost-Benefit Analysis ; Evaluation Studies as Topic ; Financing, Government ; Humans ; Inventions ; National Institutes of Health (U.S.) ; Point-of-Care Testing ; Public-Private Sector Partnerships/organization & administration ; RNA, Viral/analysis ; Reagent Kits, Diagnostic/supply & distribution ; SARS-CoV-2/immunology ; Sensitivity and Specificity ; Spike Glycoprotein, Coronavirus/analysis ; Spike Glycoprotein, Coronavirus/immunology ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling.
Autorzy :
Klumpp-Thomas C; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, 20850, USA.; Section on Immuno-Engineering, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20894, USA.
Kalish H; Trans-NIH Shared Resource on Biomedical Engineering and Physical Science, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20894, USA.
Drew M; Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Hunsberger S; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20894, USA.
Snead K; Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Fay MP; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20894, USA.
Mehalko J; Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Shunmugavel A; Section on Immuno-Engineering, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20894, USA.
Wall V; Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Frank P; Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Denson JP; Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Hong M; Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Gulten G; Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Messing S; Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Hicks J; Trans-NIH Shared Resource on Biomedical Engineering and Physical Science, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20894, USA.
Michael S; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, 20850, USA.
Gillette W; Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Hall MD; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, 20850, USA.
Memoli MJ; LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20894, USA.
Esposito D; Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Sadtler K; Section on Immuno-Engineering, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20894, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Jan 04; Vol. 12 (1), pp. 113. Date of Electronic Publication: 2021 Jan 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
COVID-19 Testing*
Antibodies, Viral/*blood
COVID-19/*diagnosis
Enzyme-Linked Immunosorbent Assay/*methods
Enzyme-Linked Immunosorbent Assay/*standards
SARS-CoV-2/*immunology
Antibodies, Viral/immunology ; COVID-19/blood ; COVID-19/epidemiology ; COVID-19/immunology ; COVID-19 Nucleic Acid Testing ; COVID-19 Serological Testing/methods ; COVID-19 Serological Testing/standards ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Pandemics ; Reference Standards ; Sensitivity and Specificity ; Spike Glycoprotein, Coronavirus/immunology
Czasopismo naukowe
Tytuł :
SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic.
Autorzy :
Venugopal U; Department of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Jilani N; Department of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Rabah S; Department of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Shariff MA; Department of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Jawed M; Department of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Mendez Batres A; Department of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Abubacker M; Department of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Menon S; Department of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Pillai A; Department of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Shabarek N; Department of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Kasubhai M; Department of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Dimitrov V; Department of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA.
Menon V; Department of Medicine, NYC Health + Hospitals/Lincoln, 234 East 149th Street, Bronx, New York, 10451, USA. Electronic address: .
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Jan; Vol. 102, pp. 63-69. Date of Electronic Publication: 2020 Oct 16.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Serological Testing*
Health Personnel*
COVID-19/*epidemiology
Adult ; COVID-19/diagnosis ; COVID-19 Nucleic Acid Testing ; Cross-Sectional Studies ; Female ; Hospitals, Urban ; Humans ; Male ; Middle Aged ; New York City/epidemiology ; Pandemics ; SARS-CoV-2/isolation & purification ; Seroepidemiologic Studies
Czasopismo naukowe
Tytuł :
Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19.
Autorzy :
Böger B; Pharmaceutical Sciences Postgraduate Program, Health Sciences Sector, Federal University of Paraná, Curitiba, Brazil.
Fachi MM; Pharmaceutical Sciences Postgraduate Program, Health Sciences Sector, Federal University of Paraná, Curitiba, Brazil.
Vilhena RO; Department of Pharmacy, Federal University of Paraná, Curitiba, Brazil.
Cobre AF; Pharmaceutical Sciences Postgraduate Program, Health Sciences Sector, Federal University of Paraná, Curitiba, Brazil.
Tonin FS; Pharmaceutical Sciences Postgraduate Program, Health Sciences Sector, Federal University of Paraná, Curitiba, Brazil.
Pontarolo R; Department of Pharmacy, Federal University of Paraná, Curitiba, Brazil. Electronic address: .
Pokaż więcej
Źródło :
American journal of infection control [Am J Infect Control] 2021 Jan; Vol. 49 (1), pp. 21-29. Date of Electronic Publication: 2020 Jul 10.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
COVID-19 Nucleic Acid Testing*
COVID-19 Serological Testing*
COVID-19/*diagnosis
Lung/*diagnostic imaging
Antibodies, Viral/immunology ; COVID-19/immunology ; COVID-19 Testing ; Coronavirus Envelope Proteins/genetics ; Coronavirus RNA-Dependent RNA Polymerase/genetics ; Humans ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology ; Sensitivity and Specificity ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe.
Autorzy :
Rusakaniko S; Faculty of Medicine and Health Sciences, University of Zimbabwe, Avondale, Harare, Zimbabwe of Zimbabwe.
Sibanda EN; Asthma Allergy and Immunology Clinic, Twin Palms Medical Centre, Harare, Zimbabwe.; Department of Pathology, National University of Science and Technology Medical School, Bulawayo, Zimbabwe.
Mduluza T; Department of Biotechnology and Biochemistry, University of Zimbabwe, Mount Pleasant, Harare, Zimbabwe.
Tagwireyi P; Department of Geography and Environmental Science, Geo-information and Earth Observation Centre, University of Zimbabwe, Mount Pleasant, Harare, Zimbabwe.
Dhlamini Z; Department of Pathology, National University of Science and Technology Medical School, Bulawayo, Zimbabwe.
Ndhlovu CE; Faculty of Medicine and Health Sciences, University of Zimbabwe, Avondale, Harare, Zimbabwe of Zimbabwe.
Chandiwana P; Faculty of Medicine and Health Sciences, University of Zimbabwe, Avondale, Harare, Zimbabwe of Zimbabwe.
Chiwambutsa S; Faculty of Medicine and Health Sciences, University of Zimbabwe, Avondale, Harare, Zimbabwe of Zimbabwe.
Lim RM; Institute of Immunology & Infection Research, University of Edinburgh, Ashworth Laboratories, Edinburgh, United Kingdom.; NIHR Global Health Research Unit Tackling Infections to Benefit Africa (TIBA), University of Edinburgh, Ashworth Laboratories, Edinburgh, United Kingdom.
Scott F; Institute of Immunology & Infection Research, University of Edinburgh, Ashworth Laboratories, Edinburgh, United Kingdom.; NIHR Global Health Research Unit Tackling Infections to Benefit Africa (TIBA), University of Edinburgh, Ashworth Laboratories, Edinburgh, United Kingdom.
Sibanda LM; Iam4BYO-Fighting COVID-19, Castell Court, Bulawayo, Zimbabwe.
Mutapi F; Institute of Immunology & Infection Research, University of Edinburgh, Ashworth Laboratories, Edinburgh, United Kingdom.; NIHR Global Health Research Unit Tackling Infections to Benefit Africa (TIBA), University of Edinburgh, Ashworth Laboratories, Edinburgh, United Kingdom.
Pokaż więcej
Źródło :
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2021 Mar 31; Vol. 15 (3), pp. e0009254. Date of Electronic Publication: 2021 Mar 31 (Print Publication: 2021).
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19 Serological Testing*
Health Personnel*
COVID-19/*epidemiology
Adolescent ; Adult ; Aged ; COVID-19/prevention & control ; COVID-19/transmission ; COVID-19 Nucleic Acid Testing ; Comorbidity ; Female ; Health Facilities ; Humans ; Male ; Middle Aged ; Occupational Diseases/epidemiology ; Occupational Diseases/prevention & control ; Occupational Health ; Pandemics ; Risk Factors ; SARS-CoV-2 ; Seroepidemiologic Studies ; Young Adult ; Zimbabwe/epidemiology
Czasopismo naukowe
Tytuł :
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
Autorzy :
Weis S; Institute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University, Jena, Germany; Centre for Sepsis Control and Care (CSCC), Jena University Hospital - Friedrich Schiller University, Jena, Germany; Department of Anaesthesiology and Intensive Care, Jena University Hospital - Friedrich Schiller University, Jena, Germany. Electronic address: .
Scherag A; Institute of Medical Statistics, Computer and Data Sciences, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
Baier M; Institute of Medical Microbiology, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
Kiehntopf M; Institute of Clinical Chemistry and Laboratory Diagnostics and Integrated Biobank Jena (IBBJ), Jena University Hospital - Friedrich Schiller University, Jena, Germany.
Kamradt T; Institute of Immunology, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
Kolanos S; Institute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
Ankert J; Institute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
Glöckner S; Institute of Medical Microbiology, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
Makarewicz O; Institute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
Hagel S; Institute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
Bahrs C; Institute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University, Jena, Germany; Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
Kimmig A; Institute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
Proquitté H; Children's Hospital, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
Guerra J; Institute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University, Jena, Germany; Centre for Sepsis Control and Care (CSCC), Jena University Hospital - Friedrich Schiller University, Jena, Germany.
Rimek D; Thuringian State Office for Consumer Protection, Bad Langensalza, Germany.
Löffler B; Institute of Medical Microbiology, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
Pletz MW; Institute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
Pokaż więcej
Corporate Authors :
CoNAN Study Group
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Mar; Vol. 27 (3), pp. 470.e1-470.e9. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Serological Testing*
Antibodies, Viral/*blood
COVID-19/*epidemiology
SARS-CoV-2/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Asymptomatic Infections/epidemiology ; COVID-19/diagnosis ; COVID-19/immunology ; COVID-19/prevention & control ; COVID-19 Nucleic Acid Testing ; Child ; Child, Preschool ; Cohort Studies ; Female ; Germany/epidemiology ; Humans ; Immunoglobulin G/blood ; Infant ; Male ; Middle Aged ; RNA, Viral/genetics ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification ; Seroepidemiologic Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Audio Interview: Covid-19 and the States - A Conversation with Ralph Northam.
Autorzy :
Rubin EJ
Baden LR
Northam RS
Morrissey S
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Feb 04; Vol. 384 (5), pp. e25.
Typ publikacji :
Editorial; Interview
MeSH Terms :
COVID-19 Vaccines*/supply & distribution
SARS-CoV-2*
State Government*
COVID-19/*prevention & control
Immunization Programs/*organization & administration
Adenoviridae ; COVID-19/epidemiology ; COVID-19 Testing/statistics & numerical data ; Communication ; Genetic Vectors ; Health Education ; Humans ; Treatment Outcome ; Virginia/epidemiology
Opinia redakcyjna
Tytuł :
Interest of the cellular population data analysis as an aid in the early diagnosis of SARS-CoV-2 infection.
Autorzy :
Vasse M; Biology Department, Foch Hospital& UMR-S 1176, Suresnes and Kremlin-Bicêtre, France.
Ballester MC; Emergency Unit, Foch Hospital, Suresnes, France.
Ayaka D; Biology Department, Foch Hospital, Suresnes, France.
Sukhachev D; LabTech Ltd, Saint-Petersburg, Russia.
Delcominette F; Biology Department, Foch Hospital, Suresnes, France.
Habarou F; Biology Department, Foch Hospital, Suresnes, France.
Jolly E; Biology Department, Foch Hospital, Suresnes, France.
Sukhacheva E; Beckman Coulter Eurocenter, Nyon, Switzerland.
Pascreau T; Biology Department, Foch Hospital& UMR-S 1176, Suresnes and Kremlin-Bicêtre, France.
Farfour É; Biology Department, Foch Hospital, Suresnes, France.
Pokaż więcej
Źródło :
International journal of laboratory hematology [Int J Lab Hematol] 2021 Feb; Vol. 43 (1), pp. 116-122. Date of Electronic Publication: 2020 Aug 19.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
COVID-19 Testing*
Early Diagnosis*
Leukocyte Count*
Pandemics*
SARS-CoV-2*
COVID-19/*diagnosis
Adolescent ; Adult ; Aged ; Aged, 80 and over ; COVID-19/blood ; COVID-19/diagnostic imaging ; COVID-19/epidemiology ; COVID-19 Nucleic Acid Testing ; Decision Trees ; False Negative Reactions ; False Positive Reactions ; Female ; Humans ; Leukocytes/classification ; Male ; Middle Aged ; Predictive Value of Tests ; Prospective Studies ; ROC Curve ; Reverse Transcriptase Polymerase Chain Reaction ; Supervised Machine Learning ; Tomography, X-Ray Computed ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies